{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,19]],"date-time":"2025-08-19T10:07:56Z","timestamp":1755598076784,"version":"3.37.3"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Investigation"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.resinv.2024.12.005","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T13:02:24Z","timestamp":1734354144000},"page":"109-117","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Predictive factors of progression in mild fibrosing interstitial lung disease patients with gender-age-physiology score of 3 or less"],"prefix":"10.1016","volume":"63","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9298-3504","authenticated-orcid":false,"given":"Masaki","family":"Okamoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomonori","family":"Chikasue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2212-0631","authenticated-orcid":false,"given":"Toyoshi","family":"Yanagihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4524-4813","authenticated-orcid":false,"given":"Kazuhiro","family":"Tabata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"Zaizen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaki","family":"Tominaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akiko","family":"Sumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Takeoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norikazu","family":"Matsuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Nouno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsushi","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoaki","family":"Hoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.resinv.2024.12.005_bib1","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","article-title":"Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"205","author":"Raghu","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib2","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib3","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.2009-040GL","article-title":"An official ATS\/ERS\/JRS\/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management","volume":"183","author":"Raghu","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib4","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib5","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1164\/rccm.201403-0566OC","article-title":"Epidemiologic survey of Japanese patients with idiopathic pulmonary fibrosis and investigation of ethnic differences","volume":"190","author":"Natsuizaka","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib6","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1164\/rccm.202205-0910LE","article-title":"Patient characteristics and survival for progressive pulmonary fibrosis using different definitions","volume":"207","author":"Khor","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib7","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1056\/NEJMoa1402584","article-title":"Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis","volume":"370","author":"Richeldi","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib8","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1056\/NEJMoa1402582","article-title":"A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis","volume":"370","author":"King","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib9","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1016\/j.chest.2021.06.049","article-title":"Impact of antifibrotic therapy on mortality and acute exacerbation in idiopathic pulmonary fibrosis: a systematic Review and meta-analysis","volume":"160","author":"Petnak","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.12.005_bib10","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","article-title":"Nintedanib in progressive fibrosing interstitial lung diseases","volume":"381","author":"Flaherty","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib11","doi-asserted-by":"crossref","first-page":"684","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib12","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1378\/chest.13-1474","article-title":"Predicting survival across chronic interstitial lung disease: the ILD-GAP model","volume":"145","author":"Ryerson","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.12.005_bib13","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S2213-2600(19)30255-3","article-title":"Biomarkers of extracellular matrix turnover in patients with idiopathic pulmonary fibrosis given nintedanib (INMARK study): a randomised, placebo-controlled study","volume":"7","author":"Maher","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib14","doi-asserted-by":"crossref","first-page":"5536","DOI":"10.1007\/s12325-023-02668-x","article-title":"Effect of nintedanib in patients with progressive pulmonary fibrosis in subgroups with differing baseline characteristics","volume":"40","author":"Kolb","year":"2023","journal-title":"Adv Ther"},{"key":"10.1016\/j.resinv.2024.12.005_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1183\/23120541.00127-2018","article-title":"Effects of nintedanib in patients with idiopathic pulmonary fibrosis by GAP stage","volume":"5","author":"Ryerson","year":"2019","journal-title":"ERJ Open Res"},{"key":"10.1016\/j.resinv.2024.12.005_bib16","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1164\/rccm.202005-2032ST","article-title":"Diagnosis of hypersensitivity pneumonitis in adults. An official ATS\/JRS\/ALAT clinical practice guideline","volume":"202","author":"Raghu","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib17","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2024.12.005_bib18","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib19","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League against Rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.resinv.2024.12.005_bib20","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1136\/annrheumdis-2016-210571","article-title":"American College of Rheumatology\/European League against Rheumatism classification criteria for primary Sjogren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"76","author":"Shiboski","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.resinv.2024.12.005_bib21","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/art.41773","article-title":"2021 American college of rheumatology\/vasculitis foundation guideline for the management of antineutrophil cytoplasmic antibody-associated vasculitis","volume":"73","author":"Chung","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.resinv.2024.12.005_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-40508-8","article-title":"Cohort study to evaluate prognostic factors in idiopathic pulmonary fibrosis patients introduced to oxygen therapy","volume":"13","author":"Kataoka","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.12.005_bib23","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-2600(23)00461-7","article-title":"GOLD COPD report: 2024 update","volume":"12","author":"Venkatesan","year":"2024","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib24","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/j.1440-1843.2009.01479.x","article-title":"Development of an activity of daily living scale for patients with COPD: the Activity of Daily Living Dyspnoea scale","volume":"14","author":"Yoza","year":"2009","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2024.12.005_bib25","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1378\/chest.107.6.1585","article-title":"Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD","volume":"107","author":"Mahler","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.12.005_bib26","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2169\/internalmedicine.56.7019","article-title":"Depression is significantly associated with the health status in patients with idiopathic pulmonary fibrosis","volume":"56","author":"Matsuda","year":"2017","journal-title":"Intern Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib27","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1164\/rccm.2111053","article-title":"Idiopathic pulmonary fibrosis: a composite physiologic index derived from disease extent observed by computed tomography","volume":"167","author":"Wells","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib28","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardization of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.12.005_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1164\/ajrccm.166.1.at1102","article-title":"ATS statement: guidelines for the six-minute walk test","volume":"166","year":"2002","journal-title":"Guideline Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib30","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0009-9260(82)80301-2","article-title":"Computed tomography in pulmonary emphysema","volume":"33","author":"Goddard","year":"1982","journal-title":"Clin Radiol"},{"key":"10.1016\/j.resinv.2024.12.005_bib31","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1513\/AnnalsATS.202002-122RL","article-title":"Diagnostic features in combined pulmonary fibrosis and emphysema: a systematic Review","volume":"17","author":"Wong","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2024.12.005_bib32","doi-asserted-by":"crossref","first-page":"8881","DOI":"10.1038\/s41598-022-13131-2","article-title":"Quantitative evaluation of emphysema for predicting immunotherapy response in patients with advanced non-small-cell lung cancer","volume":"12","author":"Noda","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.resinv.2024.12.005_bib33","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/resp.13138","article-title":"Disease severity staging system for idiopathic pulmonary fibrosis in Japan","volume":"22","author":"Kondoh","year":"2017","journal-title":"Respirology"},{"key":"10.1016\/j.resinv.2024.12.005_bib34","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1186\/s12890-021-01595-3","article-title":"Efficacy of early antifibrotic treatment for idiopathic pulmonary fibrosis","volume":"21","author":"Sugino","year":"2021","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib35","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1164\/rccm.200302-219OC","article-title":"Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia","volume":"168","author":"Lama","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib36","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1183\/09031936.00152609","article-title":"A simple assessment of dyspnoea as a prognostic indicator in idiopathic pulmonary fibrosis","volume":"36","author":"Nishiyama","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.resinv.2024.12.005_bib37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1164\/rccm.200604-520OC","article-title":"Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis","volume":"174","author":"Lederer","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib38","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1164\/rccm.201007-1179OC","article-title":"Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference","volume":"183","author":"du Bois","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.resinv.2024.12.005_bib39","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1513\/AnnalsATS.201807-443OC","article-title":"Computed tomography honeycombing identifies a progressive fibrotic phenotype with increased mortality across diverse interstitial lung diseases","volume":"16","author":"Adegunsoye","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.resinv.2024.12.005_bib40","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1016\/j.chest.2021.03.066","article-title":"Diagnosis and evaluation of hypersensitivity pneumonitis: CHEST guideline and expert panel report","volume":"160","author":"Fern\u00e1ndez P\u00e9rez","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.12.005_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pulmoe.2019.08.007","article-title":"Comparative survival analysis between idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis","volume":"26","author":"Alberti","year":"2020","journal-title":"Pulmonology"},{"key":"10.1016\/j.resinv.2024.12.005_bib42","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1136\/thoraxjnl-2017-210035","article-title":"Change in FVC and survival in chronic fibrotic hypersensitivity pneumonitis","volume":"73","author":"Gimenez","year":"2018","journal-title":"Thorax"},{"key":"10.1016\/j.resinv.2024.12.005_bib43","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.12-2685","article-title":"Identifying an inciting antigen is associated with improved survival in patients with chronic hypersensitivity pneumonitis","volume":"144","author":"Fern\u00e1ndez P\u00e9rez","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.resinv.2024.12.005_bib44","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.chest.2018.08.1076","article-title":"Hypersensitivity pneumonitis: radiologic phenotypes are associated with distinct survival time and pulmonary function trajectory","volume":"155","author":"Salisbury","year":"2019","journal-title":"Chest"}],"container-title":["Respiratory Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524001928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212534524001928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:05:36Z","timestamp":1740146736000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212534524001928"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2212534524001928"],"URL":"https:\/\/doi.org\/10.1016\/j.resinv.2024.12.005","relation":{},"ISSN":["2212-5345"],"issn-type":[{"type":"print","value":"2212-5345"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predictive factors of progression in mild fibrosing interstitial lung disease patients with gender-age-physiology score of 3 or less","name":"articletitle","label":"Article Title"},{"value":"Respiratory Investigation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resinv.2024.12.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Japanese Respiratory Society. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}